Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.
Kim H, Yoon HM, Kim EK, Ra YS, Kim HW, Yum MS, Kim MJ, Baek JS, Sung YS, Lee SM, Lim HS, Lee BJ, Lim HT, Kim D, Yoon J, Bae H, Hwang S, Choi YH, Kim KA, Choi IH, Lee SW, Park SJ, Lee BH.
Kim H, et al. Among authors: sung ys.
Neuro Oncol. 2024 Jul 8:noae121. doi: 10.1093/neuonc/noae121. Online ahead of print.
Neuro Oncol. 2024.
PMID: 38975694